Step-up versus top-down: application of new biological agents in pediatric inflammatory bowel disease

Editorial

William A Faubion. Clin Gastroenterol Hepatol. 2006 Sep.

. 2006 Sep;4(9):1094-6.

doi: 10.1016/j.cgh.2006.06.015. Epub 2006 Aug 8.

No abstract available

Comment on

The natural history of corticosteroid therapy for ulcerative colitis in children.
Hyams J, Markowitz J, Lerer T, Griffiths A, Mack D, Bousvaros A, Otley A, Evans J, Pfefferkorn M, Rosh J, Rothbaum R, Kugathasan S, Mezoff A, Wyllie R, Tolia V, delRosario JF, Moyer MS, Oliva-Hemker M, Leleiko N; Pediatric Inflammatory Bowel Disease Collaborative Research Group. Hyams J, et al. Clin Gastroenterol Hepatol. 2006 Sep;4(9):1118-23. doi: 10.1016/j.cgh.2006.04.008. Epub 2006 Jul 3. Clin Gastroenterol Hepatol. 2006. PMID: 16820327
Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease.
Markowitz J, Hyams J, Mack D, Leleiko N, Evans J, Kugathasan S, Pfefferkorn M, Mezoff A, Rosh J, Tolia V, Otley A, Griffiths A, Moyer MS, Oliva-Hemker M, Wyllie R, Rothbaum R, Bousvaros A, Del Rosario JF, Hale S, Lerer T; Pediatric IBD Collaborative Research Group. Markowitz J, et al. Clin Gastroenterol Hepatol. 2006 Sep;4(9):1124-9. doi: 10.1016/j.cgh.2006.05.011. Epub 2006 Jul 24. Clin Gastroenterol Hepatol. 2006. PMID: 16861053